Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Release of mitochondrial cytochrome c resulting in downstream activation of cell death pathways has been suggested to play a role in neurologic diseases featuring cell death. However, the specific biologic importance of cytochrome c release has not been demonstrated in Huntington's disease (HD). To evaluate the role of cytochrome c release, we screened a drug library to identify new inhibitors of cytochrome c release from mitochondria. Drugs effective at the level of purified mitochondria were evaluated in a cellular model of HD. As proof of principle, one drug was chosen for in depth evaluation in vitro and a transgenic mouse model of HD. Our findings demonstrate the utility of mitochondrial screening to identify inhibitors of cell death and provide further support for the important functional role of cytochrome c release in HD. Given that many of these compounds have been approved by the Food and Drug Administration for clinical usage and cross the blood–brain barrier, these drugs may lead to trials in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826 · cited 2×
“…cell death pathways, both caspase-dependent and independent, is a promising avenue of research, as they are of documented importance to neurodegeneration (Beal, 1999; Li et al., 2001; Yu et al., 2002; Zhu et al., 2002; Friedlander, 2003; Wang et al., 2003; Zhang et al., 2003; Chan, 2004).”
BackgroundSelf-citationEndonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787 · cited 2×
“…cell death pathways, both caspase-dependent and independent, is a promising avenue of research, as they are of documented importance to neurodegeneration (Beal, 1999; Li et al., 2001; Yu et al., 2002; Zhu et al., 2002; Friedlander, 2003; Wang et al., 2003; Zhang et al., 2003; Chan, 2004).”
BackgroundSelf-citationβ-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 1×
“The effectiveness of screening this particular library has been demonstrated by several publications by a number of independent laboratories identifying potential new neuroprotective drugs (Aiken et al., 2004; Stavrovskaya et al., 2004; Rothstein et al., 2005; W. Wang et al., 2005).”
BackgroundWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 8×
“…been accomplished in a broad verity of models in a number of independent laboratories (Yrjänheikki et al., 1999; Chen et al., 2000; Sanchez Mejia et al., 2001; Brundula et al., 2002; Wu et al., 2002; Zhu et al., 2002; Friedlander, 2003; Hersch et al., 2003; Wang et al., 2003; Stack et al., 2006).”
BackgroundInfluentialTetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · cited 7×
“…survival in animal models of ALS and HD, and exhibits neuroprotective properties in experimental models of Parkinson disease and multiple sclerosis (Yrjänheikki et al., 1998; Chen et al., 2000; Sanchez Mejia et al., 2001; Brundula et al., 2002; Wu et al., 2002; Zhu et al., 2002; Friedlander,…”
BackgroundInfluentialTikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · cited 1×
“In addition to inhibiting cytochrome c release, minocycline either directly or indirectly inhibits reactive microgliosis, p38MAPK, and poly(ADP-ribose) polymerase (Tikka et al., 2001; Wu et al., 2002; Alano et al., 2006).”
BackgroundThe NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · cited 1×
“It is however of interest that a number of publications have failed to demonstrated neuroprotection mediated by minocycline (Diguet et al., 2003; Smith et al., 2003; NINDS NET-PD Investigators, 2006).”
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.11.002 · Cited by 114 · cited 3×
“Indeed, R6/2 mice are widely used for studying novel drug therapies for the human disease (Ona et al., 1999; Chen et al., 2000; Li et al., 2005; Stack et al., 2006).”
BackgroundSelf-citation
Cited by
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Melatonin: A Multitasking Molecule
Reiter, R. J., Tan, D.-X., & Fuentes-Broto, L. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(08)81008-4 · Cited by 642
Hüttemann, M., Pecina, P., Rainbolt, M., Sanderson, T. H., Kagan, V. E., Samavati, L., Doan, J. W., & Lee, I. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.01.010 · Cited by 522
Calcium signaling and neurodegenerative diseases
Bezprozvanny, I. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.001 · Cited by 469
Suofu, Y., Li, W., Jean-Alphonse, F. G., Jia, J., Khattar, N. K., Li, J., Baranov, S. V., Leronni, D., Mihalik, A. C., He, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705768114 · Cited by 414
Self-citation
Metadata
- Authors
- Wang, X., Zhu, S., Pei, Z., Drozda, M., Stavrovskaya, I. G., Del Signore, S. J., Cormier, K., Shimony, E. M., Wang, H., Ferrante, R. J., Kristal, B. S., & Friedlander, R. M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-09-17
- Volume
- 28
- Issue
- 38
- Pages
- 9473-9485
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2030307679
- Cited by
- 120
- References
- 9
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease. https://app.cochat.ai/papers/10.1523/jneurosci.1867-08.2008
- The paper
- Wang, X., Zhu, S., Pei, Z., Drozda, M., Stavrovskaya, I. G., Del Signore, S. J., Cormier, K., Shimony, E. M., Wang, H., Ferrante, R. J., Kristal, B. S., & Friedlander, R. M. (2008). Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.1867-08.2008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.